Doxorubicin Hydrochloride

CAS 25316-40-9 12 current records 3 historicalSmall Molecule

Who holds supplier records for Doxorubicin Hydrochloride? 12 organisations hold a current record for Doxorubicin Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), Japan (2), India (1), Italy (1) and 4 other countries (4); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Doxorubicin Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/doxorubicin-hydrochloride

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Doxorubicin Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Zhejiang Hisun Pharmaceutical Co., Ltd.
    Active DMF 27311, 13773 · latest filing Sept 2013
    ChinaCEP Company GMP cert on record
  • DZD (Heze) Pharmaceutical Co., Ltd.
    Active DMF 31153 · latest filing Nov 2016
    ChinaCEP Company GMP cert on record
  • Intas Pharmaceuticals Ltd.
    Active DMF 34545 · latest filing Jan 2020
    IndiaCEP Company GMP cert on record
  • Meiji Seika Pharma Co., Ltd.
    Active DMF 13209 · latest filing Apr 1998
    JapanCEP
  • MICROBIOPHARM JAPAN CO LTD
    Active DMF 13211 · latest filing Apr 1998
    JapanCEP Company GMP cert on record
  • OLON SPA
    Active DMF 30035 · latest filing Nov 2015
    ItalyCEP Company GMP cert on record
  • SYNBIAS PHARMA AG
    Active DMF 16178 · latest filing Oct 2002
    SwitzerlandCEP
  • TAPI NL BV
    Active DMF 13726 · latest filing Sept 1998
    NetherlandsCEP
  • PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INC
    Active DMF 2098 · latest filing Apr 1973
  • STERLING BIOTECH LTD
    Active DMF 24858 · latest filing Apr 2011
    United StatesCEP
  • BORYUNG PHARMACEUTICAL CO LTD
    CEP
  • GermanyCEP Company GMP cert on record
Need Doxorubicin Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (11)

Certificates of Suitability on the EDQM register for Doxorubicin Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
STERLING BIOTECH LIMITED VadodaraIN
CEP 2012-039 - Rev 02
Doxorubicin Hydrochloride
Jun 2026—
INTAS PHARMACEUTICALS LIMITED AhmedabadIN
CEP 2012-367 - Rev 03
Doxorubicin Hydrochloride
Mar 2026—
TAPI NL B.V. AmsterdamNL
CEP 2003-111 - Rev 07
Doxorubicin Hydrochloride
Jul 2025—
DZD (HEZE) PHARMACEUTICAL CO., LTD. Heze CityCN
CEP 2016-254 - Rev 01
Doxorubicin Hydrochloride
Jun 2025Inspected Nov 2023
Germany
Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou CityCN
CEP 1999-151 - Rev 09
Doxorubicin Hydrochloride
Oct 2024—
OLON S.P.A. RodanoIT
CEP 2017-169 - Rev 04
Doxorubicin Hydrochloride
May 2024Inspected Mar 2025
Italy
TRANSO-PHARM HANDELS GMBH SiekDE
R1-CEP 2004-059 - Rev 03
Doxorubicin Hydrochloride
Mar 2023—
SYNBIAS PHARMA AG SchaffhausenCH
R0-CEP 2020-186 - Rev 00
Doxorubicin Hydrochloride
Sept 2022—
MEIJI SEIKA PHARMA CO., LTD. TokyoJP
R1-CEP 2003-151 - Rev 03
Doxorubicin Hydrochloride
Apr 2020—
BORYUNG PHARMACEUTICAL CO., LTD. SeoulKR
R1-CEP 2010-324 - Rev 01
Doxorubicin Hydrochloride, Synthetic
Jul 2017—
MICROBIOPHARM JAPAN CO., LTD. TokyoJP
R1-CEP 2004-200 - Rev 05
Doxorubicin Hydrochloride
Mar 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Doxorubicin Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 3 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Doxorubicin Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL359744).

Chemical identity

IUPAC name
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
Canonical SMILES
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl
InChIKey
MWWSFMDVAYGXBV-RUELKSSGSA-N
Synonyms
Adriablastina cs, Adriamycin, Adriamycin, hydrochloride, Adriamycin pfs, Adriamycin rdf, Caelyx, Caelyx pegylated liposomal, Celdoxome pegylated liposomal, Doxil, Doxil (liposomal), Doxorubicin citrate, Doxorubicin citric acid salt

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Anthracycline Topoisomerase Inhibitor
Mechanism of action
Topoisomerase Inhibitors
Chemical structure
Anthracyclines

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Doxorubicin Hydrochloride?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Doxorubicin Hydrochloride: Zhejiang Hisun Pharmaceutical Co., Ltd. (China), DZD (Heze) Pharmaceutical Co., Ltd. (China), Intas Pharmaceuticals Ltd. (India), Meiji Seika Pharma Co., Ltd. (Japan), MICROBIOPHARM JAPAN CO LTD (Japan), OLON SPA (Italy), SYNBIAS PHARMA AG (Switzerland) and TAPI NL BV (Netherlands), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Doxorubicin Hydrochloride Drug Master Files are active?

Zhejiang Hisun Pharmaceutical Co., Ltd. (DMF 27311, 13773), DZD (Heze) Pharmaceutical Co., Ltd. (DMF 31153), Intas Pharmaceuticals Ltd. (DMF 34545), Meiji Seika Pharma Co., Ltd. (DMF 13209), MICROBIOPHARM JAPAN CO LTD (DMF 13211), OLON SPA (DMF 30035), SYNBIAS PHARMA AG (DMF 16178) and TAPI NL BV (DMF 13726) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Doxorubicin Hydrochloride records mean?

3 organisations have only inactive Type II DMFs for Doxorubicin Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Doxorubicin Hydrochloride have a European Certificate of Suitability?

Yes. 11 organisations hold a valid CEP for Doxorubicin Hydrochloride on the EDQM register, including STERLING BIOTECH LIMITED Vadodara (IN), INTAS PHARMACEUTICALS LIMITED Ahmedabad (IN), TAPI NL B.V. Amsterdam (NL), DZD (HEZE) PHARMACEUTICAL CO., LTD. Heze City (CN), Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City (CN) and OLON S.P.A. Rodano (IT) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Doxorubicin Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Doxorubicin Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.